Milestone Asset Management LLC Makes New $1.04 Million Investment in HealthEquity, Inc. $HQY

Milestone Asset Management LLC acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) during the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 10,925 shares of the company’s stock, valued at approximately $1,035,000.

A number of other institutional investors also recently bought and sold shares of the stock. Farther Finance Advisors LLC grew its position in HealthEquity by 232.4% during the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after purchasing an additional 172 shares during the last quarter. WPG Advisers LLC acquired a new stake in shares of HealthEquity during the first quarter worth $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of HealthEquity during the second quarter valued at $33,000. Cullen Frost Bankers Inc. increased its position in shares of HealthEquity by 172.3% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after acquiring an additional 224 shares during the period. Finally, Northwestern Mutual Wealth Management Co. raised its stake in HealthEquity by 176.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock worth $58,000 after acquiring an additional 418 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 1,500 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president directly owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This represents a 1.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the sale, the executive vice president owned 45,742 shares in the company, valued at $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 17,240 shares of company stock worth $1,640,164. Company insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on HQY. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $120.00 price target on shares of HealthEquity in a report on Friday, December 5th. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. increased their price objective on shares of HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $120.27.

View Our Latest Stock Analysis on HealthEquity

HealthEquity Trading Down 0.2%

HealthEquity stock opened at $92.47 on Thursday. The firm has a market cap of $7.90 billion, a PE ratio of 42.42, a P/E/G ratio of 1.34 and a beta of 0.18. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65. The stock’s 50 day simple moving average is $97.21 and its two-hundred day simple moving average is $96.03. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQYGet Free Report) last posted its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same period in the previous year, the firm earned $0.78 EPS. The business’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

About HealthEquity

(Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Featured Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.